The Cancer Genome Atlas Biospecimen Core Resource
What is the BCR?
A critical need for The Cancer Genome Atlas Pilot Project was the selection and development of the Human Cancer Biospecimen Core Resource (BCR) at IGC to qualify, provide quality assurance and distribute human biomolecules to researchers. The BCR will mitigate the risk of variability introduced by the collection, processing and handling of tissues.
The Cancer Genome Atlas Pilot Project is utilizing our current clinical research infrastructures to build a well-defined and robust prospective biospecimen collection process. Standard procedures are used for all steps, including informed consent, clinical data collection, sample collection, pathology review, biomolecule extractions, quality control, laboratory data collection, and biomolecule distribution. The BCR is helping the pilot project to address important issues such as the cellular heterogeneity (polyclonality, stromal and vascular infiltration, microenvironment and its complex role) and the stability of the biomolecules used for the studies.
For more information about The Cancer Genome Atlas, please visit The Cancer Genome Atlas's Web site at http://cancergenome.nih.gov.
